Celgene and Juno Announce Celgene Exercised Option to Develop and Commercialize CD19-directed Product Candidates
Syntholene Completes Phase One of Effects Testing at Iceland Demonstration Facility, Advances to High-Power Operations
VanadiumCorp Completes Rock Chip Sampling Program at its Lac Doré Vanadium-Iron-Titanium Project; 53 Samples Submitted to AGAT Laboratories for Analysis
